Reims, United Kingdom

Christine M P Lambert

This inventor holds 1 USPTO granted patent. Top assignee: Astra Zeneca U.k. Limited. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christine M P Lambert. Retrieved from https://idiyas.com/inventor/christine-m-p-lambert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Christine M P Lambert

Introduction

Christine M P Lambert is a notable inventor based in Reims, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on quinazoline derivatives. His research focuses on developing compounds that can be used in the prevention and treatment of T cell mediated diseases.

Latest Patents

Christine M P Lambert holds a patent for quinazoline derivatives, which are characterized by a specific formula that includes a quinazoline ring. These derivatives can be substituted with various groups, such as halogeno, trifluoromethyl, and cyano. The invention also encompasses processes for their preparation, pharmaceutical compositions containing them, and their application in manufacturing medicaments for treating medical conditions in warm-blooded animals.

Career Highlights

Christine M P Lambert is associated with Astra Zeneca U.K. Limited, where he has been instrumental in advancing pharmaceutical research. His work has led to the development of innovative solutions that address critical health issues.

Collaborations

He has collaborated with esteemed colleagues, including Graham C Crawley and Laurent F A Hennequin, to further enhance the impact of his research and inventions.

Conclusion

Christine M P Lambert's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to improving health outcomes. His work continues to influence the development of new treatments for various medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…